Clinical Trials Sponsored by NIHON MEDI-PHYSICS CO.,LTD.

Total 38 results

Nihon Medi-Physics Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
Emory University
Nihon Medi-Physics Co., Ltd.

Completed

Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule (SPN)

Lung Cancer

United States
Emory University
Blue Earth Diagnostics; Nihon Medi-Physics Co., Ltd.

Completed

FACBC Prostate Therapy Response

Prostate Cancer

United States
Nihon Pharmaceutical Co., Ltd

Completed

Study of NPF-08 in Patients Who Receive Colonoscopy

Patients Who Receive Colonoscopy

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy

Bowel Disease

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy

Patients Undergoing Gastrointestinal Endoscopy

China
Nihon Pharmaceutical Co., Ltd

Completed

Phase I/II Clinical Trial of NPF-08 in Healthy Volunteers

Healthy Volunteers

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Stevens-Johnson Syndrome | Toxic Epidermal Necrolysis

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Gastric Cancer | Gastric Adenoma | Colon Nos Polypectomy Tubular Adenoma

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Gastric Cancer

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

Healthy

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

Patients Undergoing Gastric Endoscopy

Japan
Nihon Pharmaceutical Co., Ltd

Recruiting

Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis

Autoimmune Encephalitis

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Study of NPO-13 During Colonoscopy

Bowel Disease

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis

Portal Vein Thrombosis

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.

Multifocal Motor Neuropathy

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids. (NPB-01)

Bullous Pemphigoid

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.

Neuromyelitis Optica Spectrum Disorder

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Chronic Inflammatory Demyelinating Polyneuropathy

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

Bullous Pemphigoid

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

Stomach Diseases

Japan
Translational Research Center for Medical Innovation...
Johnson & Johnson; Codman & Shurtleff; Eisai Limited; Nihon Medi-Physics Co., Ltd. and other collaborators

Completed

Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus

Idiopathic Normal Pressure Hydrocephalus

Japan
Chung Mei Biopharma Co., Ltd

Not yet recruiting

Safety and Efficacy of DCB-BO1301 in Advanced Melanoma

Advanced Melanoma
Pell Bio-Med Technology Co., Ltd.

Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma | Follicular Lymphoma Grade 3B | Follicular Lymphoma Grade 3A

Taiwan
Pell Bio-Med Technology Co., Ltd.

Recruiting

Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma

Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma | Follicular Lymphoma Grade 3B | Follicular Lymphoma Grade 3A

Taiwan
Med Pharma Co., Ltd.
Fidia Farmaceutici s.p.a.

Completed

Efficacy and Safety of Intraarticular Injections of Hyalgan in the Treatment of Osteoarthritis of the Knee

Osteoarthritis

Taiwan
Chi Mei Medical Hospital
GeneFerm Biotechnology Co., Ltd.

Completed

Efficacy and Safety of Geneferm Nattokinase

Hyperlipidemia

Taiwan
Peking University People's Hospital
Shanghai Hansen Biopharmaceutical Technology Co., Ltd; MEDx Translational Medicine...

Recruiting

Soluble B7-H3 as a Biomarker for Osteosarcoma

Progression | Osteosarcoma | Surveillance | Biomarker

China
Omron Healthcare Co., Ltd.
Elon University, Department of Physical Therapy Education

Unknown

Efficacy of Microcurrent Therapy for Treatment of Knee Pain

Acute Knee Pain

Japan
Micell Technologies
Hefei Life Science Medical Instruments Co. Ltd.; Giant Med-Pharma Services... and other collaborators

Unknown

Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) (DESSOLVE-C)

Coronary Heart Disease

China
Mylan Inc.
Medicine Meda Pharmaceutical Information Consultancy (Beijing) Co., Ltd.

Completed

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

China
MEI HENG
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Neoplasms | Neoplasms by Site | Hematologic Diseases | Hematologic Neoplasms

China
Biocon Biologics Inc.
MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. Ltd

Completed

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Moderate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis

Bulgaria, Czechia, Estonia, Poland
Wei Liu
AstraZeneca; University of Washington; Beijing Clinstech-med consulting Co., Ltd

Unknown

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques

Carotid Atherosclerosis

China
Funan Liu
Institute of Health and Medical Technology, Hefei Institutes of Physical... and other collaborators

Recruiting

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

Colorectal Cancer | Organoids

China
Funan Liu
Institute of Health and Medical Technology, Hefei Institutes of Physical... and other collaborators

Recruiting

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

Gastric Cancer | Organoids

China
First Affiliated Hospital of Wenzhou Medical University
Shanghai Zhongshan Hospital; The First Affiliated Hospital of Zhengzhou University and other collaborators

Recruiting

Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics

Chronic Obstructive Pulmonary Disease

China

Clinical Trials Sponsored by NIHON MEDI-PHYSICS CO.,LTD.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations